87. Vaccines as a Tool to Combat Antimicrobial Resistance
Thursday, October 8, 2015: 2:00 PM-3:30 PM
Room: 6--DE
National Foundation for Infectious Diseases

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • identify the status of potential of Staph aureus vaccines to combat antimicrobial resistance
  • discuss the current and potential impact of pneumococcal vaccine antimicrobial resistance
  • review the potential opportunities and challenges in successfully developing new vaccines that could combat antimicrobial resistance

Target Audience: Vaccinologists, Scientists, Researchers, Public health practitioners, Pharmacists, Nurses, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Pediatric ID, Global ID, Epidemiology and Infection Control, Adult ID

Moderators:  Patrick Joseph, MD, FIDSA, University of California, San Francisco and Andrew Pavia, MD, FIDSA, FSHEA, FPIDS, University of Utah School of Medicine

2:00 PM
Staphylococcus aureus Vaccines
Robert S Daum, MD, FIDSA
2:30 PM
Pneumococcal Vaccines
Keith Klugman, MD, PhD, FIDSA

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-155-L01-P


P. Joseph, None

A. Pavia, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.